Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | G-CSF | 16.0 | 47 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | G-CSF | 12.0 | 75 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 14.0 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 11.0 | 71 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 11.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 11.5 | 72 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 9.0 | 77 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | G-CSF | 10.0 | 75 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | G-CSF | 13.0 | 112 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 13.5 | 68 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 11.0 | 77 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 10.0 | 88 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 13.0 | 65 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | G-CSF | 11.5 | 72 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | G-CSF | 11.5 | 56 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 368.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 34.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 21.0 | 75 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 262.5 | 76 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 348.0 | 68 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 13.0 | 64 | |
RA2159 | PI103 | 0.1 | uM | 3 | G-CSF | 10.0 | 80 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 834.5 | 84 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 138.0 | 71 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | G-CSF | 564.0 | 83 |